Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Jan-24 8:28 PM View:  | Nokes Rachael CFO and Treasurer | Scpharmaceuticals Inc. (SCPH) | 18-Jan-24 | Grant | 41,840 | -- | -- | 203% 20.57K to 62.41K | |
| 22-Jan-24 8:27 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 18-Jan-24 | Grant | 113,560 | -- | -- | 81% 140.65K to 254.21K | |
| 03-Jan-24 4:48 PM View: | Nokes Rachael CFO and Treasurer | Scpharmaceuticals Inc. (SCPH) | 02-Jan-24 | Payment of Exercise | 1,027 | $6.39 | $6,562.53 | (5%) 21.59K to 20.57K | |
| 03-Jan-24 4:31 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 02-Jan-24 | Payment of Exercise | 4,942 | $6.39 | $31,579.40 | (3%) 145.59K to 140.65K | |
| 23-Jan-23 5:54 PM View: | Nokes Rachael See Remarks | Scpharmaceuticals Inc. (SCPH) | 19-Jan-23 | Grant | 11,700 | $6.14 | $71,838.00 | 118% 9.89K to 21.59K | |
| 23-Jan-23 5:58 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 19-Jan-23 | Grant | 66,665 | $6.14 | $409,323.00 | 84% 78.92K to 145.59K | |
| 29-Nov-22 4:36 PM View: | Orbimed Advisors LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 25-Nov-22 | Market Purchase | 762,380 | $5.25 | $4,002,500.00 | 16% 4.8M to 5.56M | (21%) |
| 11-Oct-22 7:10 PM View: | 5am Partners Iv, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 10-Oct-22 | Market Sale | 562,466 | $4.09 | $2,300,490.00 | (17%) 3.3M to 2.73M | (1%) |
| 11-Oct-22 6:06 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 07-Oct-22 | Option Exercise | 42,250 | -- | -- | 90% 46.96K to 89.21K | |
| 11-Oct-22 6:06 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 07-Oct-22 | Payment of Exercise | 10,288 | $4.98 | $51,234.20 | (12%) 89.21K to 78.92K | |
| 11-Oct-22 7:10 PM View: | 5am Partners Iv, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 06-Oct-22 | Market Sale | 37,534 | $5.02 | $188,421.00 | (1%) 3.33M to 3.3M | 17% |
| 08-Sep-22 7:58 PM View: | 5am Partners Iv, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 07-Sep-22 | Sale | 200,000 | $4.75 | $950,000.00 | (6%) 3.53M to 3.33M | |
| 08-Sep-22 7:58 PM View: | 5am Partners Iv, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 06-Sep-22 | Private Sale | 26,622 | $5.52 | $146,953.00 | (< 1%) 3.56M to 3.53M | |
| 13-Apr-22 4:51 PM View: | 5am Partners Iv, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 11-Apr-22 | Market Sale | 270,000 | $5.00 | $1,350,000.00 | (7%) 3.83M to 3.56M | 17% |
| 06-Dec-21 5:53 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 03-Dec-21 | Market Purchase | 10,000 | $3.96 | $39,553.00 | 27% 36.96K to 46.96K | (2%) |
| 06-Dec-21 5:55 PM View: | Khattar Jack A. Director | Scpharmaceuticals Inc. (SCPH) | 03-Dec-21 | Market Purchase | 5,000 | $3.91 | $19,569.00 | 100% 0 to 5.0K | (< 1%) |
| 16-Mar-21 4:30 PM View: | Ra Capital Management, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 15-Mar-21 | Market Sale | 110,588 | $7.03 | $777,788.00 | (4%) 2.84M to 2.73M | (2%) |
| 16-Mar-21 4:30 PM View: | Ra Capital Management, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 12-Mar-21 | Market Sale | 39,469 | $7.22 | $284,816.00 | (1%) 2.88M to 2.84M | < 1% |
| 23-Jan-23 5:54 PM View: | Nokes Rachael See Remarks | Scpharmaceuticals Inc. (SCPH) | 25-Feb-21 | Payment of Exercise | 1,976 | $7.27 | $14,365.50 | (17%) 11.87K to 9.89K | 44% |
| 02-Jul-20 4:18 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 30-Jun-20 | Option Exercise | 42,250 | -- | -- | 845% 5.0K to 47.25K | |
| 02-Jul-20 4:18 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 30-Jun-20 | Payment of Exercise | 10,288 | $7.36 | $75,719.70 | (22%) 47.25K to 36.96K | 25% |
| 28-May-20 9:12 PM View: | Schwab Andrew J. 10% Owner | Scpharmaceuticals Inc. (SCPH) | 26-May-20 | Market Purchase | 578,034 | $8.65 | $4,999,990.00 | 18% 3.25M to 3.83M | (36%) |
| 26-May-20 4:44 PM View: | Orbimed Advisors LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-May-20 | Market Purchase | 1,387,280 | $8.65 | $12,000,000.00 | 41% 3.41M to 4.8M | (36%) |
| 23-Jan-23 5:54 PM View: | Nokes Rachael See Remarks | Scpharmaceuticals Inc. (SCPH) | 25-Feb-20 | Payment of Exercise | 1,981 | $10.09 | $19,988.30 | (14%) 13.85K to 11.87K | 60% |
| 19-Feb-20 4:30 PM View: | Ra Capital Management, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 14-Feb-20 | Market Purchase | 271,993 | $8.20 | $2,230,340.00 | 9% 2.98M to 3.25M | (32%) |
| 17-Dec-19 4:16 PM View: | Tucker John H President and CEO Director | Scpharmaceuticals Inc. (SCPH) | 13-Dec-19 | Market Purchase | 5,000 | $5.24 | $26,188.50 | 100% 0 to 5.0K | 6% |
| 15-Apr-19 4:31 PM View: | Ra Capital Management, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 11-Apr-19 | Market Purchase | 389,862 | $2.70 | $1,052,630.00 | 14% 2.86M to 3.25M | 106% |
| 20-Dec-17 4:18 PM View: | Schaeffer Leonard D Director | Scpharmaceuticals Inc. (SCPH) | 19-Dec-17 | Option Exercise | 22,631 | $1.66 | $37,567.50 | 29% 77.92K to 100.55K | |
| 24-Nov-17 4:33 PM View: | Sun Pharmaceutical Industri... 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion | 1,810,540 | -- | -- | 100% 0 to 1.81M | |
| 21-Nov-17 7:24 PM View: | Lundbeckfond Invest A/s 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Purchase | 654,762 | $14.00 | $9,166,670.00 | 26% 2.53M to 3.18M | |
| 21-Nov-17 7:13 PM View: | Orbimed Advisors LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion | 2,576,530 | -- | -- | 100% 0 to 2.58M | |
| 21-Nov-17 7:22 PM View: | Agger Mette Kirstine Director 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion Duplicate | 2,529,220 | -- | -- | 100% 0 to 2.53M | |
| 21-Nov-17 7:27 PM View: | Schaeffer Leonard D Director | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion | 34,818 | -- | -- | 100% 0 to 34.82K | |
| 21-Nov-17 7:13 PM View: | Orbimed Advisors LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Purchase | 833,333 | $14.00 | $11,666,700.00 | 32% 2.58M to 3.41M | |
| 24-Nov-17 4:33 PM View: | Sun Pharmaceutical Industri... 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Purchase | 357,143 | $14.00 | $5,000,000.00 | 20% 1.81M to 2.17M | |
| 21-Nov-17 7:16 PM View: | 5am Partners Iv, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion | 2,598,680 | -- | -- | 2500% 103.94K to 2.7M | |
| 21-Nov-17 7:24 PM View: | Lundbeckfond Invest A/s 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion | 2,529,220 | -- | -- | 100% 0 to 2.53M | |
| 21-Nov-17 7:27 PM View: | Schaeffer Leonard D Director | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion | 43,104 | -- | -- | 124% 34.82K to 77.92K | |
| 21-Nov-17 7:16 PM View: | 5am Partners Iv, LLC 10% Owner | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Purchase Duplicate | 654,762 | $14.00 | $9,166,670.00 | 24% 2.7M to 3.36M | |
| 21-Nov-17 7:17 PM View: | Silverstein Jonathan Director | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion Duplicate | 2,576,530 | -- | -- | 100% 0 to 2.58M | |
| 21-Nov-17 7:24 PM View: | Coleman Dorothy Director | Scpharmaceuticals Inc. (SCPH) | 21-Nov-17 | Conversion | 14,348 | -- | -- | 100% 0 to 14.35K |
